chrisvoncsefalvay/vaers-outcomes huggingface dataset:
so many symptoms from the first dose; chills; fever over 100F; achy all over; arm was hurting so much; 5-6 inches in diameter lump in the arm; skin was red; warm to touch; couldn't lay on my left side; shortness of breath; diarrhea; like having Covid all over again; was in bed all the time; So tired and fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (so many symptoms from the first dose), CHILLS (chills), PYREXIA (fever over 100F), PAIN (achy all over) and PAIN IN EXTREMITY (arm was hurting so much) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.   The patient's past medical history included COVID-19. Concomitant products included APIXABAN (ELIQUIS), ATORVASTATIN, MONTELUKAST, FUROSEMIDE, LOSARTAN, ISOSORBIDE, CLOPIDOGREL and DILTIAZEM for an unknown indication, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000).  On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (so many symptoms from the first dose), CHILLS (chills), PYREXIA (fever over 100F), PAIN (achy all over), PAIN IN EXTREMITY (arm was hurting so much), VACCINATION SITE MASS (5-6 inches in diameter lump in the arm), VACCINATION SITE ERYTHEMA (skin was red), INJECTION SITE WARMTH (warm to touch), DISCOMFORT (couldn't lay on my left side), DYSPNOEA (shortness of breath), DIARRHOEA (diarrhea), FEELING ABNORMAL (like having Covid all over again), ASTHENIA (was in bed all the time) and FATIGUE (So tired and fatigue). At the time of the report, ADVERSE EVENT (so many symptoms from the first dose), CHILLS (chills), PYREXIA (fever over 100F), PAIN (achy all over), PAIN IN EXTREMITY (arm was hurting so much), VACCINATION SITE MASS (5-6 inches in diameter lump in the arm), VACCINATION SITE ERYTHEMA (skin was red), INJECTION SITE WARMTH (warm to touch), DISCOMFORT (couldn't lay on my left side), DYSPNOEA (shortness of breath), DIARRHOEA (diarrhea), FEELING ABNORMAL (like having Covid all over again), ASTHENIA (was in bed all the time) and FATIGUE (So tired and fatigue) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details included Tylenol.
4 days after the 2nd booster my arm was no longer sore, but got sick and run down, upset stomach and digestive track, serious loss of energy.  No breathing issues. Energy gone for several days.  No indoor contact with people after shot and live alone.  Seldom get sick.  Wondered if I ate something spoiled.  Wondered how people could even go to work, or carry on, the next day after the local news was gutted, but didn't think it would made me physically sick.   Doctor is insensitive, and treats me like trash so I didn't even call him or his stupid office yet.
past the expiration date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (past the expiration date) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (past the expiration date). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (past the expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.
a 31 year old man who received the  COVID-19 vaccine on March 27, 2021 in the  Public Health Department parking lot. Upon arrival and check in, the patient declined any comorbidities and health history but did state that he was nervous. After administration of the vaccine by  NP, the patient lowered himself to the ground, from a sitting position, and had a 60 second tonic clonic seizure. Seizure precautions such as turning the patient on his side, supporting his head, and calling EMS were taken during the seizure. After 60 seconds, the patient came to and asked what happened. PPHD staff oriented the patient to what had happened, to which he proceeded to say ?oh that is normal for me when I get anxious.? With the help of PPHD staff and his wife, the patient was brought to a sitting position and given a granola bar and water to his request. According to clinic lead RN, ?his skin was normal in appearance for race, ethnicity, and age. He was mildly diaphoretic. He verbalized feelings of anxiety and worry surrounding the vaccine.?   As EMS arrived on the scene and began assessing vital signs the patients anxiety appeared to increase; he became less verbal, closed his eyes, and his breathing pattern became shallow. The patient then had a second seizure at this time lasting approximately 25 seconds. When the patient came to he immediately verbalized, ?I?m good, I?m good, I?m fine?. He was slow to respond to verbal cues, but persistently refused transport to the local acute care hospital for further evaluation. He rested on the ground in supine position for approximately 25 minutes, with his partner and EMS at his side. Upon further evaluation of the patient and his wife, it was determined that the patient has a history of seizure activities when he is nervous and that he was ?expecting? this to happen. The patient continued to decline medical care and transportation to the hospital. The patient left in medically stable condition with his wife operating the vehicle.
symptoms like fever; nausea; chills; dizziness; fatigue; This is a spontaneous report from a Pfizer-sponsored program from a consumer. A female patient of an unspecified age received her first single dose of BNT162B2 (Pfizer-BioNTech Covid-19 vaccine) via an unspecified route of administration on 19Mar2021 for Covid-19 immunization. The patient's concomitant medications were not reported. Before the first dose, she got Covid-19. After the first dose, she developed symptoms like fever, nausea, chills, dizziness and fatigue. The outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Extreme chills (teeth chattering) Fatigue low-grade fever Sleeplessness Shortness of breath during exersion
This spontaneous report as received from a health professional refers to a 4-year-old patient (gender was not reported). There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 11-NOV-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt.'s mother states that after receiving 1st dose of Phizer 07/09/2021, started experiencing symptoms 07/23/2021 of vertigo, dizziness, vision (blurriness), and nausea. Still continuing, Urgent Care visit 07/26/2021 recommended rest, Blood Work *Eosophinils High.
Approximately 3 hr post vacc -> localized erythema, pain, swelling. Approximately 12 hrs post vacc -> diffuse reaction spread to elbow; febrile 101.3 degrees. Definitive diagnosis per MD: cellulitis. Treatment ROCEPHIN 1gm x 1, AUGMENTIN 875 po BID, prednisone.
Extreme Tiredness, Severe Body ache Chills, Severe pain at injection site Tylenol PRN taken with very little effect.  Symptoms resolved on 12.26.20 around 8 AM
Pt recv vax on 7/22/97; on 3/2/99 pt exp chicken pox rash x 4 days
A patient was seen on 09/18/2020 by a nurse in the immunization clinic and received a PCV 13 vaccine. She called on 10/26/2020 to report that she believes that the nurse that administered the vaccine may have administered it to high up on her arm. She states that she has been in so much pain that she had to go to her primary care physician (PCP)  to get an MRI which she claims shows that she has tendinitis in her left arm that she claims her PCP states was caused by an injection to her rotator cuff. She called again this morning and stated that she is taking two pain medications because of this (Methyltrdnisol and Diclofenac).
Strong reaction; Face became swollen; Skin rash became much worse; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (Strong reaction), SWELLING FACE (Face became swollen) and RASH (Skin rash became much worse) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product (DUPIXENT) for Atopic dermatitis.    No Medical History information was reported.   In April 2021, the patient started DUPILUMAB (DUPIXENT) (unknown route) 300 milligram. In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced IMMUNISATION REACTION (Strong reaction), SWELLING FACE (Face became swollen) and RASH (Skin rash became much worse). In 2021, IMMUNISATION REACTION (Strong reaction), SWELLING FACE (Face became swollen) and RASH (Skin rash became much worse) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.  The reporter assessed all the events as related to Moderna vaccine and not related to Dupixent.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna
Initial report was received on 15 May 2014 from a health care professional. A 32 year-old female patient (age also reported as 33 years-old) with no reported past medical history had received on 15 May 2014 an intramuscular right deltoid injection of ADACEL, lot number C4565BA and an unspecified amount time later the same date, developed throat swelling, chest tightness, difficulty breathing and tingling up and down her right arm. The patient had been observed for 15 minutes after vaccination before she left the office, but came back a short time later with the complaints. The patient was taken to the ER (emergency room) "next door to office". The patient had no illness at the time of vaccination and was being seen for a routine visit. No further information was available at the time of the report. Outcome was unknown. Documents held by sender: none.
Missed second dose; Covid-19; Cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), COVID-19 (Covid-19) and PRODUCT DOSE OMISSION ISSUE (Missed second dose) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced COUGH (Cough). On 30-Mar-2021, the patient experienced COVID-19 (Covid-19). On 01-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose). At the time of the report, COUGH (Cough), COVID-19 (Covid-19) and PRODUCT DOSE OMISSION ISSUE (Missed second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. The patient did not receive any treatment.
Hives on buttocks and back of legs, disappeared by morning, came back the next night.
Reported itching and 4x4mm vesicular blister after 3rd Hep B vaccine one day after injection. Upper arm slightly pink, no itching/tenderness. Treat with hydrocortisol topically or oral BENADRYL.
Left arm at injection site and upper arm swollen and very hot one day after injection. Took Benadryl and applied ice. Improving.
Arm hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A, and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY. At the time of the report, PAIN IN EXTREMITY had not resolved.            Concomitant medications included thyroid and blood pressure pills.  Action taken with response to the events are not applicable   This case was linked to MOD-2021-071176. Sender's Comments: MOD-2021-071176: 1st dose of vaccine.
Pt had low grade fever of 100.0 otic at 10pm on 6/10/2022 which awakened him out of sleep.  No medications were given as he was able to soothe back to sleep with parent.  Pt slept restless after that, rolling around often in crib in parent's room, seemed unsettled overall.  at 3am on 06/11/22 mom felt weird, jerky movements happening in the room and pt was making grunting sounds.  Pt was picked up, taken to lighted living room and found to have whole body convulsions from the core and was stiffened while it was happening.  He had eyes rolled back, foaming at mouth, and was noted to likely be breathing. There was no noted color change.  Parents called EMS immediately.  The seizure lasted about 5 minutes total, which was 2 minutes prior to EMS arrival.  No CPR initiated.  After seizure, pt was quiet with eyes closed, had good color to skin, and was breathing.  1-2 min after the seizure stopped, pt started crying, still with eyes closed but was noted by EMS on arrival to be limp.   He was transported by ambulance to ER where he appeared confused, limp, awake but not moving his arms or legs.  He was noted to have Todds Paralysis for several hours.  Pt only wanted to sleep until about 06:30am on 6/11/22 in the ER.  He was then willing to walk, was alert and upset.  He was discharged with diagnosis of febrile seizure, simple.  The highest temp documented during this episode with EMS was 99.4 axillary.  in the ER, his Tmax was 100.9 at 4:25 am and was given tylenol and motrin there.  No further seizure or febrile activity.  Discharged home later that morning.  Noted that a rash started on 06/15/22 in the morning on his neck then spread to legs, arms, trunk.  Not itchy or bothersome.
Pt. states that after receiving the 1st dose of Moderna 08/25/2021, started experiencing symptoms immediately of heavy chest, shortness of breath, and fatigued. Primary visit 08/27/2021 recommended for follow-up with other Physicians. EKG low heart rate. Still continuing experiencing symptoms.
NAUSEA; FIBROMYALGIA; This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included fibromyalgia. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020 and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced fibromyalgia. On 08-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fibromyalgia, and the outcome of nausea was not reported. This report was non-serious.
This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 01/25/2021, 02/15/2021, and 04/25/2021. They tested positive for COVDI-19 on 08/10/2022 and 08/11/2022. They were hospitalized for cough, shortness of breath, confusion, and increased oxygen needs 08/10/2022-08/12/2022. They were diagnosed with several complications and co-occurring conditions, including: acute metabolic encephalopathy secondary to viral infection, viral bronchitis, hypoxemia, and were found to have had a recent right hemisphere ischemic stroke. They were discharged to assisted living facility. They then presented to emergency department on 08/26/2022 with primary complaint of persistent headache. The primary care provider had concern of possibility of brain bleed. They were evaluated and released without being admitted to hospital. The individual died on 09/17/2022. I see no indication that they were hospitalized closer to the date of death. Despite length of time between the positive COVID-19 test and the death date, COVID-19 is still on the death certificate.
Patient became pale and had drop in HR from baseline of mid 50's (per pt report) to HR 33 (when placed on pulse oximeter) immediately following vaccine administration. Pt reported history of vasovagal response with previous injections, but did not disclose this until after vaccine administration.  A & O, no LOC.  After placing supine and feet elevated, HR returned to mid 50s bpm. Sinus bradycardia maintained.  BP WNL. SPO2 WNL on RA throughout event.  Pt monitored for 30 minutes after vasovagal event.
Patient had the COVID vaccine 5 days prior to admission, this was followed by diarrhea, body aches, intermittent shortness of breath and general feeling unwell.  Most resolved but the diarrhea and intermittent respiratory distress,  this worsened on day of admission (4/11/21) with decline in mental status.  Nausea with no vomiting, no fever, no cough.  Patient was admitted to the ICU with acute respiratory failure with hypoxia and pneumonia.  Placed on BiPAP, IV fluids.  Patient is currently in the ICU with diagnosis encephalopathy, bilateral aspiration pneumonia, right pleural effusion and UTI.  Discussed patient with Health Department who requested patient be reported to VEARS for review.
Fever and vomiting for an estimated 12 hours.  Currently 16 weeks pregnant, due date 10/30/21.
This spontaneous report was received from a licensed practical nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 08-JUN-2017, the patients were vaccinated with an improperly stored dose of VAQTA (lot # N005274, expiration date: 03-APR-2018) (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 0 to 1 Celsius degree for 1 hour 19 minutes. This is one of three cases from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA005015: US-009507513-1706USA005016.
Sore arm with a dark round bruise where the shot was given,  Swollen node under right arm pit. glucose level rise. felt very weak and dizzy. Hard to breath at times.
Medical condition worsen; Trigeminal neuralgia; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Medical condition worsen) and TRIGEMINAL NEURALGIA (Trigeminal neuralgia) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Trigeminal neuralgia. Concomitant products included CARBAMAZEPINE for Trigeminal neuralgia.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1.    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONDITION AGGRAVATED (Medical condition worsen) and TRIGEMINAL NEURALGIA (Trigeminal neuralgia). At the time of the report, CONDITION AGGRAVATED (Medical condition worsen) and TRIGEMINAL NEURALGIA (Trigeminal neuralgia) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Updated reporter information. The outcome of the event changed from unknown to resolved.
hands & feet go out & pt stiffens up-lasting about 2 seconds, then screams & cries out very loudly & hard;easily comforted afterwards;this has happened 3x in the past 10 days;1st time 2-3 days p/vax; last time 2 days ago;
Dose given was 0.5ml instead of the 0.25ml Booster Dose required.
Red, hot, swollen injection site with minimal hemorrhage. Rest, moist heat, NSAID use.
Fever of about 102F for ~ 8 hrs then broke at 5 am; then runny nose; felt better after that
Pain in leg; It's hard to get up; Sore and cramping in her toes; flu like symptoms; Can't do dusting and simple activities that require bending; Bending down has become difficult; Hurting backs of my legs; pain in hips; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in leg), HYPOKINESIA (It's hard to get up), MUSCLE SPASMS (Sore and cramping in her toes), INFLUENZA LIKE ILLNESS (flu like symptoms) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can't do dusting and simple activities that require bending) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in leg), HYPOKINESIA (It's hard to get up), MUSCLE SPASMS (Sore and cramping in her toes), INFLUENZA LIKE ILLNESS (flu like symptoms), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can't do dusting and simple activities that require bending), MOVEMENT DISORDER (Bending down has become difficult), PAIN IN EXTREMITY (Hurting backs of my legs) and ARTHRALGIA (pain in hips). At the time of the report, PAIN IN EXTREMITY (Pain in leg), HYPOKINESIA (It's hard to get up), MUSCLE SPASMS (Sore and cramping in her toes), INFLUENZA LIKE ILLNESS (flu like symptoms), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can't do dusting and simple activities that require bending), MOVEMENT DISORDER (Bending down has become difficult), PAIN IN EXTREMITY (Hurting backs of my legs) and ARTHRALGIA (pain in hips) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Ankle brachial index: high (High) High.         The patient is on five different medication for her preexisting medical condition which she did not share. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Severe Covid infection lasting 2 weeks with fever, joint pain, blood clots, severe chest pain, etc. , then following another 2 weeks chest pain, difficulty breathing, dizziness, shortness of breath, joint pain lasting another 2 weeks with severity. Do not feel completely normal yet.